Danielle Sliter, Ph.D.

Danielle Sliter, Ph.D. Email and Phone Number

Business Development and Portfolio Strategy @ Latus Bio
Rockville, MD, US
Danielle Sliter, Ph.D.'s Location
Rockville, Maryland, United States, United States
Danielle Sliter, Ph.D.'s Contact Details

Danielle Sliter, Ph.D. work email

Danielle Sliter, Ph.D. personal email

n/a
About Danielle Sliter, Ph.D.

I'm “all-in” kind of person, motivated by a deep drive to make a positive impact in the world. I dive in, fully to whatever is in front of me, from science and drug development, to my family and community building, from teaching and mentoring to outdoor adventuring. I am passionate, creative and determined in everything I do. My greatest professional joy comes from connecting concepts and leading the science, people and functions so that a strategy can be fully formed and its potential realized commercially to have the maximum impact to patients. I love to find efficiencies, and identify creative solutions to optimize drug development from discovery to the clinic and the company's portfolio strategy. This is what I am best at: seeing the Big Picture and bridging the gap in between the science (R&D) and the business case (Commercial), from either side, to allow for aligned portfolio and research strategies. - I use my deep scientific expertise to develop strategies to address significant unmet need, and collaborate cross-functionally to deliver innovative and impactful solutions for patients. - I translate strategic vision into tactical action from early research to product development with a focus on commercial impact. - I articulate vision, as a whole or in it's component parts, to any audience at any level. - I use my knowledge, experience and the power of communication to influence decisions, teach and inspire, and steer strategic direction. With these skills and my experience, I could fit into and excel in many roles, across several functions, where strategic thinking, scientific understanding, business acumen and collaborative leadership is required.I thrive by proactively improving my knowledge & skills so that I can take-on new challenges, whether personally: supporting my husband's brewery venture (Third Hill Brewing), or professionally: enabling scientific advances and for enriching my career prospects. I am excited to explore opportunities that allow for the intersection of science with business, to bring forward the most innovate and impactful solutions for patients.

Danielle Sliter, Ph.D.'s Current Company Details
Latus Bio

Latus Bio

View
Business Development and Portfolio Strategy
Rockville, MD, US
Website:
latusbio.com
Employees:
33
Danielle Sliter, Ph.D. Work Experience Details
  • Latus Bio
    Business Development And Portfolio Strategy
    Latus Bio
    Rockville, Md, Us
  • Latus Bio
    Associate Director Business Development
    Latus Bio Jul 2024 - Present
    Business Development, Investor Relations and Portfolio Strategy; functioning at the intersection of science and business to advance company objectives, support financing and long-term company growth through strategic partnerships and portfolio planning.
  • Astrazeneca
    Ad, Global Project And Program Management
    Astrazeneca Mar 2024 - Jul 2024
    Gaithersburg, Maryland, United States
    Program management of high-priority discovery stage antibody-drug conjugate projects to accelerate to critical developmental milestones.
  • Regenxbio Inc.
    Associate Director, Portfolio Strategy And New Product Planning
    Regenxbio Inc. Jul 2022 - Nov 2023
    Rockville, Maryland, United States
    I identified, gained support for and reenergized research efforts around a compelling scientific approach to address an overlooked opportunity with high potential commercial impact - Translated primary and secondary research into business insights to inform portfolio product planning and early research project development - Developed cross-functional comparative framework for evaluation of early research programs for prioritized development - Aligned Research, Clinical and Commercial functions around strategy for development of high priority ophthalmology and neuromuscular programs using science-based benchmarks - Steered portfolio strategy and product development through communication of science and business insights to executive leadership
  • Regenxbio Inc.
    Senior Scientist
    Regenxbio Inc. Sep 2019 - Jul 2022
    Rockville, Md
    I designed and lead early research projects to establish proof-of-biology for novel gene therapies focused on neurodegeneration, movement disorders and neuroinflammation - Built a cross-functional team to execute proof-of concept studies and delivery candidate gene therapies to critical Go / No-Go decisions - Evaluated novel gene therapy concepts for prioritized development - Identified targets for and develop strategies to address unmet need in neurological diseases
  • The National Institutes Of Health
    Postdoctoral Fellow
    The National Institutes Of Health Jul 2011 - Jun 2019
    Bethesda, Md
    I lead several research projects exploring the cell biology of Parkin- and PINK1- mediated mitochondrial quality control, and its implications in the development of Parkinson's disease. I forged a new path in the Youle Lab and explored a novel hypothesis that damaged mitochondria that can not be cleared due to mutations in Parkin and PINK1 could trigger innate immune activation. This hypothesis led to identifying a role for the kinase TBK1 in clearing damaged mitochondria via interaction with the autophagy adapter OPTN, which was published as a co-first authorship in Nature in 2015. Most importantly, TBK1 is linked to innate immune activation in response to cytosolic DNA via activation of STING. Following up on this, my work then identified a causal role for activation of STING in the neurodegeneration of substantia nigral neurons in a mouse model of Parkinson's disease where damaged mitochondrial can not be cleared due to loss of Parkin. This work, published in Nature in 2018, has invigorated research on the role of neuroinflammatory processes in the development of neurodegenerative disease.Sliter, D.A., et. al. Nature. 2018 Lazarou, M., Sliter, D.A., Kane, L.A. et. al. Nature. 2015
  • Suny Upstate Medical University
    Postdoctoral Researcher
    Suny Upstate Medical University Jan 2011 - Jul 2011
    Syracuse, Ny
    I continued my thesis work to assess the function of candidate E3 ligases in IP3 receptor ubiquitination, and pharmacological agents in the processing of IP3 receptors for degradation. After leaving this lab, I continued in a collaborative effort using TALEN and CRISPR technology to delete candidate E3 ligases, resulting in greater understanding of the mechanism of IP3 receptor down-regulation.
  • Suny Upstate Medical University
    Graduate Student
    Suny Upstate Medical University Sep 2004 - Dec 2010
    Syracuse, Ny
    For my thesis work, I studied the ubiquitination and degradation of inositol 1,4,5 -trisphosphate (IP3) receptors. IP3 receptors are regulated Ca2+ channels that aid in sequestering Ca2+ in the endoplasmic reticulum (ER). The stimulated release of Ca2+ from ER stores is important for many cellular homeostatic processes and failure to regulate this process can lead to disease. My work focused on the signal that targets IP3 receptors for degradation following activation, ubiquitin. Realizing that traditional methods of studying ubiquitination would be cumbersome for IP3 receptor research, I developed a collaboration with the Gygi lab to use (then) cutting edge mass spectrometric techniques, resulting in the publication of two first-author papers and culminating in a Ph. D. with distinction.
  • Suny Upstate Medical University
    Medical Technician
    Suny Upstate Medical University Jul 2002 - Aug 2004
    performed routine blood chemistry, urinalysis, and microbiology testing on patient samples

Danielle Sliter, Ph.D. Skills

Molecular Biology Cell Biology Science Cell Culture Western Blotting Tissue Culture Microbiology Confocal Microscopy Molecular Cloning Chemistry Cell Fluorescence Microscopy Protein Expression Biochemistry Pcr Immunohistochemistry Life Sciences Microscopy

Danielle Sliter, Ph.D. Education Details

Frequently Asked Questions about Danielle Sliter, Ph.D.

What company does Danielle Sliter, Ph.D. work for?

Danielle Sliter, Ph.D. works for Latus Bio

What is Danielle Sliter, Ph.D.'s role at the current company?

Danielle Sliter, Ph.D.'s current role is Business Development and Portfolio Strategy.

What is Danielle Sliter, Ph.D.'s email address?

Danielle Sliter, Ph.D.'s email address is da****@****nih.gov

What schools did Danielle Sliter, Ph.D. attend?

Danielle Sliter, Ph.D. attended Suny Upstate Medical University, Syracuse University, The Clarkson School.

What are some of Danielle Sliter, Ph.D.'s interests?

Danielle Sliter, Ph.D. has interest in Other Cultures, Scuba, Reading, Science (Of Course), Running.

What skills is Danielle Sliter, Ph.D. known for?

Danielle Sliter, Ph.D. has skills like Molecular Biology, Cell Biology, Science, Cell Culture, Western Blotting, Tissue Culture, Microbiology, Confocal Microscopy, Molecular Cloning, Chemistry, Cell, Fluorescence Microscopy.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.